Company intelligence / Profile preview

PharmaBio Investments

Durham, North Carolina, United Statesdirectory.ncbiotech.org ↗
Ownership
Private
Development stage
Other
01

Overview

PharmaBio Investments is a Durham, North Carolina-based investment firm that invests in and assists entrepreneurial life science companies developing and marketing products to treat various illnesses. The company acts as a venture capital and private equity investor with a focus on biotechnology, healthcare, medical equipment, and related sectors. It does not itself develop drugs or have its own clinical pipeline but supports other companies in these areas through funding and strategic assistance

Industry
Investors

Beyond the preview

Go deeper on PharmaBio Investments.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PharmaBio Investments.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call